FDOPA in Movement Disorders and Neuro-Oncology-Reference-Cited by-同舟云学术

FDOPA in Movement Disorders and Neuro-Oncology

Published:2021-11-30 Issue: Volume: Page:121-135
ISSN:
Container-title:Hybrid PET/MR Neuroimaging
language:
Short-container-title:

Author:

Ponisio Maria Rosana^ORCID,Iranpour Pooya,Benzinger Tammie L. S.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-82367-2_13

Reference74 articles.

1. Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Geist C, et al. 3′-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab. J Nucl Med. 2012;53(1):29–36. https://doi.org/10.2967/jnumed.111.092387.

2. Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4(11):1334–6. https://doi.org/10.1038/3337.

3. Heiss WD, Wienhard K, Wagner R, Lanfermann H, Thiel A, Herholz K, et al. F-Dopa as an amino acid tracer to detect brain tumors. J Nucl Med. 1996;37(7):1180–2.

4. Herholz K, Langen KJ, Schiepers C, Mountz JM. Brain tumors. Semin Nucl Med. 2012;42(6):356–70. https://doi.org/10.1053/j.semnuclmed.2012.06.001.

5. Heiss WD, Raab P, Lanfermann H. Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med. 2011;52(10):1585–600. https://doi.org/10.2967/jnumed.110.084210.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of [¹⁸F]-FDOPA Brain PET Acquisition Times for Assessment of Parkinsonism in the Clinical Setting;American Journal of Neuroradiology;2024-04-25